This compound is a pharmaceutical intermediate with a molecular structure featuring two alcohol groups and a bicyclic framework. Its primary significance lies in its use as a building block in the synthesis of pharmaceutical compounds.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 66774-84-3
(1R,3AR,4S,7aR)-7a-methyl-1-((R)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)heptan-2-yl)octahydro-1H-inden-4-ol
Falecalcitriol impurity reference standard
(1R,3AR,4S,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)octahydro-1H-inden-4-ol
fragrance ingredient
1,1-Dimethylethyl N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamate
Boc-protected pharmaceutical intermediate
2-chloropyridine-3-sulfonyl Chloride
Pharmaceutical intermediate for sulfonamide synthesis
Alpha-keto-beta-methylvaleric acid, calcium salt
branched-chain keto acid calcium salt
1-methylcyclopropane-1-sulfonamide
pharmaceutical intermediate
(1S,3aR,4S,7aS)-1-((S)-1-(3-hydroxy-3-methylbutoxy)ethyl)-7a-methyloctahydro-1H-inden-4-ol
pharmaceutical research compound
Inhoffen Lythgoe diol
Research compound
(1R,3aR,4S,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol
MSIPWWGBPPHCBZ-KCYAQADSSA-N
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCC[C@@H]2O)C
—